These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 31282278)
1. Up-regulated lncRNA GAS5 promotes chemosensitivity and apoptosis of triple-negative breast cancer cells. Li J; Li L; Yuan H; Huang XW; Xiang T; Dai S Cell Cycle; 2019 Aug; 18(16):1965-1975. PubMed ID: 31282278 [TBL] [Abstract][Full Text] [Related]
2. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling. Zheng S; Li M; Miao K; Xu H J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177 [TBL] [Abstract][Full Text] [Related]
4. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA. Luo N; Zhang K; Li X; Hu Y J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280 [TBL] [Abstract][Full Text] [Related]
5. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer. Li M; Li A; Zhou S; Lv H; Yang W J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway. Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness. Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512 [TBL] [Abstract][Full Text] [Related]
8. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. Sun M; Jin FY; Xia R; Kong R; Li JH; Xu TP; Liu YW; Zhang EB; Liu XH; De W BMC Cancer; 2014 May; 14():319. PubMed ID: 24884417 [TBL] [Abstract][Full Text] [Related]
9. Negative regulation of lncRNA GAS5 by miR-21. Zhang Z; Zhu Z; Watabe K; Zhang X; Bai C; Xu M; Wu F; Mo YY Cell Death Differ; 2013 Nov; 20(11):1558-68. PubMed ID: 23933812 [TBL] [Abstract][Full Text] [Related]
10. Long non‑coding RNA SChLAP1 regulates the proliferation of triple negative breast cancer cells via the miR‑524‑5p/HMGA2 axis. Bai X; Zhang S; Qiao J; Xing X; Li W; Zhang H; Xie J Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846810 [TBL] [Abstract][Full Text] [Related]
11. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis. Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083 [TBL] [Abstract][Full Text] [Related]
12. YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2. Yang Z; Ding H; Pan Z; Li H; Ding J; Chen Q Cancer Biol Ther; 2021 Mar; 22(3):216-224. PubMed ID: 33683171 [TBL] [Abstract][Full Text] [Related]
13. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer. Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer. Li W; Zhai L; Wang H; Liu C; Zhang J; Chen W; Wei Q Oncotarget; 2016 May; 7(19):27778-86. PubMed ID: 27034004 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer. Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression. Wu J; Chen H; Ye M; Wang B; Zhang Y; Sheng J; Meng T; Chen H Biomed Pharmacother; 2019 Jul; 115():108869. PubMed ID: 31028999 [TBL] [Abstract][Full Text] [Related]
17. LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other. Liu AN; Qu HJ; Gong WJ; Xiang JY; Yang MM; Zhang W J Cell Biochem; 2019 Sep; 120(9):14860-14866. PubMed ID: 31033015 [TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion. Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521 [TBL] [Abstract][Full Text] [Related]
19. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer. Yan J; Wang R; Wu Z J BUON; 2019; 24(2):535-542. PubMed ID: 31128002 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA DGCR5 incudes tumorigenesis of triple-negative breast cancer by affecting Wnt/β-catenin signaling pathway. Jiang D; Wang C; He J J BUON; 2020; 25(2):702-708. PubMed ID: 32521856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]